R5 Final QA

This page is part of the FHIR Specification (v5.0.0-draft-final: Final QA Preview for R5 - see ballot notes). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B

Example EvidenceVariable/example-alteplase-for-stroke (JSON)

Clinical Decision Support Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: Not linked to any defined compartments

Raw JSON (canonical form + also see JSON Format Specification)

Alteplase for Stroke

{
  "resourceType" : "EvidenceVariable",
  "id" : "example-alteplase-for-stroke",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      \n      <p>\n        &quot;Alteplase for Stroke&quot; is an exposure concept with a detailed dosing instruction that may be used in expressing what an Evidence is about.\n      </p>\n\t\n    </div>"
  },
  "name" : "AlteplaseForStroke",
  "title" : "Alteplase for Stroke",
  "status" : "draft",
  "description" : "Alteplase for Stroke",
  "actual" : true,
  "characteristic" : [{
    "description" : "IV alteplase 0.9 mg/kg (maximum 90 mg) as 10% of dose over 1 minute and 90% over 1 hour",
    "definitionCanonical" : "http://example.org/fhir/ActivityDefinition/example-alteplase-dosing"
  }]
}

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.